Molnupiravir more effective than Favipiravir for Covid patients, says health expert in Thailand

Dr Manoon Leechawengwongs. - The Nation Thailand/ANN

BANGKOK, March 15 (The Nation Thailand/ANN): The World Health Organisation (WHO) recommends the use of antiviral Molnupiravir over Favipiravir in the treatment of Covid-19 patients, a respiratory specialist in Bangkok has said in a Facebook post on Tuesday.

Dr Manoon Leechawengwongs said WHO recommends using the Molnupiravir on patients who had been infected for less than five days.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Subscribe

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Subscribe

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only

Subscribe
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Thailand , Health Expert , Recommend , Pills , OK , WHO

   

Report it to us.

Next In Aseanplus News
India’s highest honour given to first Lao national of Indian origin
Oil inches up, but uncertainty over sanctions impact caps gains
‘Red Note’, a Chinese app, is dominating downloads, thanks to TikTok users
Ridiculous to suggest China could bail out 1MDB, says Najib
Hong Kong, Thai officials in talks to combat South-East Asian scam centres
Aerotrain contractors yet to give firm date on service resumption, says Loke
Air passenger traffic in 2024 hit 97.1 million passengers, reflects strong recovery, says Loke
Woman, 32, arrested after allegedly luring two Hongkongers to South-East Asia
Bangladesh's Yunus demands return of stolen billions
Cultural exchange enhanced through book donation

Trending in AseanPlus

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.